Cancer therapy beyond apoptosis: Autophagy and anoikis as mechanisms of cell death

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Apoptosis has long been recognized as a critical mechanism of programmed cell death that is preserved among all eukaryotes and is involved in a variety of disease processes. Malignant transformation of cells is associated with a constellation of pro-survival mutations rendering them resistant to apoptosis. Traditional cancer therapy evokes cell death by inducing apoptosis; however, the apoptotic resistance inherent in cancer cells has been a significant barrier to effective chemotherapy. More recently, other mechanisms of cell death have emerged as potential novel mechanisms for cancer therapies to induce cell death, either in addition to, or instead of, apoptosis-induced cytotoxic treatment. Autophagy is a process that occurs in all cells, but is induced in many types of cancer. Autophagy functions as both a cell survival and a cell death mechanism depending on the context and the stimuli, which are likely exploitable for cancer therapy. Anoikis is also a physiologic process in normal cells used to maintain homeostasis, in which cell death is induced in response to loss of extracellular membrane (ECM) attachment. Cancer cells are notoriously resistant to anoikis, enabling metastasis and new tumor growth beyond their original environment. Interestingly, autophagy may actually by a major contributor to anoikis resistance in cancer. As these two processes are elucidated in more detail, there is great potential for novel targets that affect cancer cell death, in addition to the current cytotoxic agents.

Original languageEnglish (US)
Pages (from-to)301-308
Number of pages8
JournalJournal of Surgical Research
Volume164
Issue number2
DOIs
StatePublished - Dec 2010

Fingerprint

Anoikis
Autophagy
Cell Death
Apoptosis
Neoplasms
Therapeutics
Cytotoxins
Eukaryota
Cell Survival
Homeostasis
Neoplasm Metastasis

Keywords

  • anoikis
  • apoptosis
  • autophagy
  • pancreatic cancer

ASJC Scopus subject areas

  • Surgery

Cite this

Cancer therapy beyond apoptosis : Autophagy and anoikis as mechanisms of cell death. / Coates, Jodi M.; Galante, Joseph M; Bold, Richard J.

In: Journal of Surgical Research, Vol. 164, No. 2, 12.2010, p. 301-308.

Research output: Contribution to journalArticle

@article{b84b0f0076954a22ab8fa957b7639299,
title = "Cancer therapy beyond apoptosis: Autophagy and anoikis as mechanisms of cell death",
abstract = "Apoptosis has long been recognized as a critical mechanism of programmed cell death that is preserved among all eukaryotes and is involved in a variety of disease processes. Malignant transformation of cells is associated with a constellation of pro-survival mutations rendering them resistant to apoptosis. Traditional cancer therapy evokes cell death by inducing apoptosis; however, the apoptotic resistance inherent in cancer cells has been a significant barrier to effective chemotherapy. More recently, other mechanisms of cell death have emerged as potential novel mechanisms for cancer therapies to induce cell death, either in addition to, or instead of, apoptosis-induced cytotoxic treatment. Autophagy is a process that occurs in all cells, but is induced in many types of cancer. Autophagy functions as both a cell survival and a cell death mechanism depending on the context and the stimuli, which are likely exploitable for cancer therapy. Anoikis is also a physiologic process in normal cells used to maintain homeostasis, in which cell death is induced in response to loss of extracellular membrane (ECM) attachment. Cancer cells are notoriously resistant to anoikis, enabling metastasis and new tumor growth beyond their original environment. Interestingly, autophagy may actually by a major contributor to anoikis resistance in cancer. As these two processes are elucidated in more detail, there is great potential for novel targets that affect cancer cell death, in addition to the current cytotoxic agents.",
keywords = "anoikis, apoptosis, autophagy, pancreatic cancer",
author = "Coates, {Jodi M.} and Galante, {Joseph M} and Bold, {Richard J}",
year = "2010",
month = "12",
doi = "10.1016/j.jss.2009.07.011",
language = "English (US)",
volume = "164",
pages = "301--308",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Cancer therapy beyond apoptosis

T2 - Autophagy and anoikis as mechanisms of cell death

AU - Coates, Jodi M.

AU - Galante, Joseph M

AU - Bold, Richard J

PY - 2010/12

Y1 - 2010/12

N2 - Apoptosis has long been recognized as a critical mechanism of programmed cell death that is preserved among all eukaryotes and is involved in a variety of disease processes. Malignant transformation of cells is associated with a constellation of pro-survival mutations rendering them resistant to apoptosis. Traditional cancer therapy evokes cell death by inducing apoptosis; however, the apoptotic resistance inherent in cancer cells has been a significant barrier to effective chemotherapy. More recently, other mechanisms of cell death have emerged as potential novel mechanisms for cancer therapies to induce cell death, either in addition to, or instead of, apoptosis-induced cytotoxic treatment. Autophagy is a process that occurs in all cells, but is induced in many types of cancer. Autophagy functions as both a cell survival and a cell death mechanism depending on the context and the stimuli, which are likely exploitable for cancer therapy. Anoikis is also a physiologic process in normal cells used to maintain homeostasis, in which cell death is induced in response to loss of extracellular membrane (ECM) attachment. Cancer cells are notoriously resistant to anoikis, enabling metastasis and new tumor growth beyond their original environment. Interestingly, autophagy may actually by a major contributor to anoikis resistance in cancer. As these two processes are elucidated in more detail, there is great potential for novel targets that affect cancer cell death, in addition to the current cytotoxic agents.

AB - Apoptosis has long been recognized as a critical mechanism of programmed cell death that is preserved among all eukaryotes and is involved in a variety of disease processes. Malignant transformation of cells is associated with a constellation of pro-survival mutations rendering them resistant to apoptosis. Traditional cancer therapy evokes cell death by inducing apoptosis; however, the apoptotic resistance inherent in cancer cells has been a significant barrier to effective chemotherapy. More recently, other mechanisms of cell death have emerged as potential novel mechanisms for cancer therapies to induce cell death, either in addition to, or instead of, apoptosis-induced cytotoxic treatment. Autophagy is a process that occurs in all cells, but is induced in many types of cancer. Autophagy functions as both a cell survival and a cell death mechanism depending on the context and the stimuli, which are likely exploitable for cancer therapy. Anoikis is also a physiologic process in normal cells used to maintain homeostasis, in which cell death is induced in response to loss of extracellular membrane (ECM) attachment. Cancer cells are notoriously resistant to anoikis, enabling metastasis and new tumor growth beyond their original environment. Interestingly, autophagy may actually by a major contributor to anoikis resistance in cancer. As these two processes are elucidated in more detail, there is great potential for novel targets that affect cancer cell death, in addition to the current cytotoxic agents.

KW - anoikis

KW - apoptosis

KW - autophagy

KW - pancreatic cancer

UR - http://www.scopus.com/inward/record.url?scp=78449281238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78449281238&partnerID=8YFLogxK

U2 - 10.1016/j.jss.2009.07.011

DO - 10.1016/j.jss.2009.07.011

M3 - Article

C2 - 20031162

AN - SCOPUS:78449281238

VL - 164

SP - 301

EP - 308

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 2

ER -